logo-loader
viewMGC Pharmaceuticals Ltd

MGC Pharma updates on ArtemiC coronavirus study and first-ever THC shipment to Brazil

MGC Pharmaceuticals Ltd's (ASX:MXC) Roby Zomer speaks to Proactive's Andrew Scott soon after announcing positive results from a pre-clinical study of ArtemiCTM on rats with no pathological changes or differences between the study groups reported. He also discusses its first-ever shipments of the Mercury Pharma line, which includes high THC products, directly to patients in Brazil through a binding supply and distribution agreement with ONIX Empreendimentos e Participações.

Quick facts: MGC Pharmaceuticals Ltd

Price: 0.021 AUD

ASX:MXC
Market: ASX
Market Cap: $35.93 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MGC Pharmaceuticals Ltd named herein, including the promotion by the Company of MGC Pharmaceuticals Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Pan African Resources expands investor base with OTCQX upgrade, reveals...

Pan African Resources plc (LON:PAF) (OTCQX:PAFRY) CEO Cobus Loots tells Proactive that the South African-based gold-mining group upgraded to trade its shares on the OTCQX Best Market, because he feels the group has a lot to offer to US investors in terms of its profits, dividends, and growth,...

11 hours, 2 minutes ago

2 min read